(Q40722123)

23 September 2017

1 reference

title

Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease (English)

1 reference

23 September 2017

Thornton CA

1

1 reference

23 September 2017

Griggs RC

series ordinal

2

1 reference

23 September 2017

publication date

1 March 1994

1 reference

23 September 2017

1 reference

23 September 2017

volume

35

1 reference

23 September 2017

issue

3

1 reference

23 September 2017

page(s)

260-268

1 reference

Uptake of plasma IgG by CNS motoneurons: comparison of antineuronal and normal IgG.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANA.410350304

In vitro immune responses to hepatitis B surface antigens S and preS2 during acute infection by hepatitis B virus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410350304

Limited relapse in Guillain-Barré syndrome after plasma exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410350304

Kinetics of anti-peripheral nerve myelin antibody in patients with Guillain-Barré syndrome treated and not treated with plasmapheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410350304

Intravenous immunoglobulin therapy of autoimmune and systemic inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410350304

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratory characteristics associated with improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410350304

High-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410350304

Open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410350304

Myasthenic crisis. Response to plasmapheresis following failure of intravenous gamma-globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410350304

High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410350304

High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410350304

Effect of plasmapheresis on serum and CSF autoantibody levels in CNS paraneoplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410350304

Safety of intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410350304

Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410350304

21 January 2018

Identifiers

DOI

10.1002/ANA.410350304

1 reference

23 September 2017

1 reference